BTX-2640

N/A

Report date: 2022/06/10 15:51:46
NME

Base Information

Drug NameBTX-2640
Drug Alias NameBTX-2640
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptor 4 antagonistsProteolysis
TargetsFibroblast growth factor receptor 4
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiotheryx Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiotheryx Inc
Inactive CompaniesN/A
Active IndicationsInflammationNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A